MentionFox
Home › funding signals › Pelthos Therapeutics Inc.
Form D · on the record

Pelthos Therapeutics Inc. — $57.50M Form D filing, November 2026

Before you sell to, join or invest in Pelthos Therapeutics Inc.

MentionFox check on Pelthos Therapeutics Inc.: only 1 source on file so far (checked 18 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/pelthos-therapeutics-inc-form-d-000142

Check Pelthos Therapeutics Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Pelthos Therapeutics Inc.?

Pelthos Therapeutics Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-16.

Pelthos Therapeutics Inc. filed a Form D notice of an exempt securities offering with the SEC on November 16, 2026. Pelthos Therapeutics Inc. trades on NYSE as PTHS; it was formerly Channel Therapeutics Corp. The filing reports $57.50M sold. Its industry group is Pharmaceuticals. It names Scott Plesha (Chief Executive Officer), John Gay (Chief Financial Officer, Treasurer and Secretary), Sai Rangarao (Chief Commercial Officer) (SEC Form D, November 16, 2026).

In its own words: “Pelthos Therapeutics is a specialty bio-pharmaceutical organization committed to commercializing innovative, safe, and efficacious therapeutic products to help patients with unmet treatment burdens.” (pelthos.com, checked November 6, 2026)

Sell to companies like Pelthos Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Pelthos Therapeutics Inc. raised on Nov 16. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Pharmaceuticals raises within 90 days of this one ↓

Selling to Pelthos Therapeutics Inc.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on Pelthos Therapeutics Inc. →

Pelthos Therapeutics Inc.

New Form D on file · 2026-11-16 · the record

$57.50M
raise on the record
D
filing
7
investors in
NORTH CAROLINA
based
Open the record →

What the record says

FilingForm D
Filed2026-11-16
Industry groupPharmaceuticals
Entity typeCorporation
Incorporated inNEVADA
BasedDurham, NORTH CAROLINA
CIK1919246
Accession0001919246-26-000142

Pitching, partnering or investing alongside them? See who really runs and owns Pelthos Therapeutics Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Pelthos Therapeutics Inc., from the filings we hold.

More raises like this

Pharmaceuticals raises filed within 90 days of this one, largest first.

What do you want to do with Pelthos Therapeutics Inc.?

Get the full cited report on Pelthos Therapeutics Inc.

What the filing shows about Pelthos Therapeutics Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 10 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Pelthos Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look Pelthos Therapeutics Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Pelthos Therapeutics Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives Pelthos Therapeutics Inc.'s address as 4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703.

What the filing says

  • Offered: $57,500,000. Sold: $57,500,000. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 7 had already invested. (filing)
  • Date of first sale: October 30, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Pelthos Therapeutics Inc. See pricing

Is Pelthos Therapeutics Inc. a real, registered company?

Pelthos Therapeutics Inc. is a registered filer with the SEC (CIK 1919246) and has filed since 2024-08-06. 5 filings are on record, the latest on 2026-11-16.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Pelthos Therapeutics Inc.?

Pelthos Therapeutics Inc.'s Form D of 2026-11-16 names Scott Plesha, John Gay, Sai Rangarao and 7 more as its officers, directors or promoters.

How much has Pelthos Therapeutics Inc. raised?

Its new offerings report $126.35M sold across 4 offerings, as its own filings state.

Filing history · 5 filings on this registrant
Form D · 2024-08-06 · $750KForm D · 2024-08-06Form D · 2025-07-10 · $50.10MForm D · 2025-11-19 · $18MForm D · 2026-11-16 · $57.50M · this page 2024-08-06 2026-11-16

Each marker is one filing. The larger marker is the filing this page is about.

Pharmaceuticals · by week
This raise, $57.50M, filed week of Nov 16

Trailing twelve months. 154 filings in Pharmaceuticals, totalled by week. The dot is this raise, $57.50M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Pelthos Therapeutics Inc.?

What the filing shows about Pelthos Therapeutics Inc.

  • 7 investors had already put money in when it filed.
  • The filing names 10 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Pelthos Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Pelthos Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Pelthos Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Pelthos Therapeutics Inc.: Raised $57.50M, Form D filed 2026-11-16
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/pelthos-therapeutics-inc-form-d-000142
Last updated 2026-11-18
Primary record: SEC filing 1 · SEC filing 2
Pelthos Therapeutics Inc. raised $57.50M — SEC Form D filing, November 2026. MentionFox, 2026-11-18. https://mentionfox.com/funding/pelthos-therapeutics-inc-form-d-000142